Performance Metrics

Concentrated Pharma ETF Outperforms but Carries Bigger Single-Stock Risk

VanEck's PPH posts stronger recent returns with a higher yield, presenting a clear trade-off between concentrated drugmaker exposure and IXJ's broader, more liquid healthcare coverage.